Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans

Sponsor
Brigham and Women's Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06105164
Collaborator
Mclean Hospital (Other), Beth Israel Deaconess Medical Center (Other)
150
2
2
54
75
1.4

Study Details

Study Description

Brief Summary

This study uses a noninvasive technique called transcranial magnetic stimulation (TMS) to study satiety in healthy individuals.

TMS is a noninvasive way of stimulating the brain, using a magnetic field to change activity in the brain. The magnetic field is produced by a coil that is held next to the scalp. In this study, the investigators will be stimulating the brain to learn more about the role of the cerebellum in satiety.

Condition or Disease Intervention/Treatment Phase
  • Device: Repetitive Transcranial Magnetic Stimulation (rTMS)
  • Device: Sham repetitive Transcranial Magnetic Stimulation (rTMS)
N/A

Detailed Description

The purpose of this study is to conduct a circuit manipulation experiment to test the hypothesis that targeting the cerebellum can alter activity in response to food cues to advance the understanding of the involvement of the cerebellar-striatal circuit in feeding behavior.

Participants will undergo an initial screening session to complete informed consent and undergo baseline assessments including physical activity and food craving. Participants will additionally undergo an MRI scan that includes structural and resting-state functional magnetic resonance imaging (rsfMRI). These rsfMRI imagines will be used to isolate individual resting state networks for targeting of rTMS modulation.

Participants will then complete two separate testing sessions involving MRI imaging and food intake assessments before and after rTMS. One visit will involve consumption of a filling meal; the other visit will be completed following an overnight fast.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Other
Official Title:
Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans
Anticipated Study Start Date :
Feb 1, 2024
Anticipated Primary Completion Date :
Aug 1, 2028
Anticipated Study Completion Date :
Aug 1, 2028

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Active cerebellar rTMS

Cerebellar targeted iTBS

Device: Repetitive Transcranial Magnetic Stimulation (rTMS)
rTMS is a technique of TMS that allows for selective external manipulation of neural activity in a non-invasive manner. During rTMS a rapidly changing current is passed through an insulated coil placed against the scalp. This generates a temporary magnetic field, which in turn induces electrical current in neurons and allows for modulation of neural circuitry. Intermittent theta burst stimulation (iTBS) consisting of 2 s trains of 3 pulses at 50 Hz, repeated at 5 Hz, every 10s for a total of 600 pulses (82), will be applied to the target. Cerebellar stimulation will be applied to the targets at 100% of aMT or 35% maximal stimulator output, whichever is higher.
Other Names:
  • iTBS
  • Sham Comparator: Sham cerebellar rTMS

    Cerebellar targeted sham iTBS

    Device: Sham repetitive Transcranial Magnetic Stimulation (rTMS)
    rTMS is a technique of TMS that allows for selective external manipulation of neural activity in a non-invasive manner. During rTMS a rapidly changing current is passed through an insulated coil placed against the scalp. This generates a temporary magnetic field, which in turn induces electrical current in neurons and allows for modulation of neural circuitry. Intermittent theta burst stimulation (iTBS) consisting of 2 s trains of 3 pulses at 50 Hz, repeated at 5 Hz, every 10s for a total of 600 pulses (82), will be applied to the target. Cerebellar stimulation will be applied to the targets at 100% of aMT or 35% maximal stimulator output, whichever is higher. Sham is achieved by using a coil with a magnetic shield preventing magnetic field from reaching the head.
    Other Names:
  • iTBS
  • Outcome Measures

    Primary Outcome Measures

    1. Change in BOLD response in the cerebellum [30 minutes pre-TMS and 30 minutes post-TMS, at each of two main study visits (fed, fasted)]

      Change in functional activation of the cerebellum will be assessed before (pre-TMS) and after (post-rTMS) rTMS stimulation, measured separately at the fed visit and at the fasted visit.

    2. Change in BOLD response in the ventral striatum [30 minutes pre-TMS and 30 minutes post-TMS, at each of two main study visits (fed, fasted)]

      Change in functional activation of the ventral striatum will be assessed before (pre-TMS) and after (post-rTMS) rTMS stimulation, measured separately at the fed visit and at the fasted visit.

    3. Change in food reward valuation [up to 60 minutes pre-TMS and up to 60 minutes post-TMS, at each of two main study visits (fed, fasted)]

      Change in food reward valuation of high-calorie foods will be assessed using the Willingness to Pay task, measured before (pre-TMS) and after (post-rTMS) rTMS stimulation, measured separately at the fed visit and at the fasted visit.

    4. Ad libitum snack food intake [baseline, up to 60 minutes post-TMS at each of two main study visits (fed, fasted)]

      Change in total caloric intake during the ad libitum snack food session will be assessed at the baseline visit and after (post-rTMS) rTMS stimulation, the latter measured separately at the fed visit and at the fasted visit.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Healthy individuals aged 18 to 65

    • BMI of 20-35.0 kg/m2

    • Normal or corrected-to-normal vision

    • Good general health

    • Ability to understand and willingness to sign written informed consent document

    Exclusion Criteria:
    • Current and/or past medical conditions

    • Current and/or past eating disorder

    • On a restricted diet and/or taking weight loss medication(s)

    • History of bariatric surgery

    • Weight fluctuation >3% in past 3 months

    • Recent history of illicit recreational drug abuse

    • Current nicotine use

    • Intellectual disability

    • Conditions that might result in increased risks of side effects or complications from TMS or MRI

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 McLean Hospital Belmont Massachusetts United States 02478
    2 Brigham and Women's Hospital Boston Massachusetts United States 02120

    Sponsors and Collaborators

    • Brigham and Women's Hospital
    • Mclean Hospital
    • Beth Israel Deaconess Medical Center

    Investigators

    • Principal Investigator: Laura Holsen, PhD, Brigham and Women's Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Laura M Holsen, Associate Professor of Psychiatry, Brigham and Women's Hospital
    ClinicalTrials.gov Identifier:
    NCT06105164
    Other Study ID Numbers:
    • 2023P002811
    First Posted:
    Oct 27, 2023
    Last Update Posted:
    Oct 27, 2023
    Last Verified:
    Oct 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes

    Study Results

    No Results Posted as of Oct 27, 2023